(Q48468500)

11 February 2018

title

Generation of antibodies specific for beta-amyloid by vaccination of patients with Alzheimer disease. (English)

1 reference

11 February 2018

0 references

0 references

1 reference

Christoph Hock

1

1 reference

11 February 2018

Uwe Konietzko

2

1 reference

11 February 2018

Andreas Papassotiropoulos

3

1 reference

11 February 2018

Axel Wollmer

4

1 reference

11 February 2018

Johannes Streffer

5

1 reference

11 February 2018

Ruth C von Rotz

6

1 reference

11 February 2018

Gabriela Davey

7

1 reference

11 February 2018

Eva Moritz

8

1 reference

11 February 2018

Roger M Nitsch

9

1 reference

11 February 2018

language of work or name

English

0 references

publication date

15 October 2002

1 reference

11 February 2018

published in

Nature Medicine

1 reference

11 February 2018

volume

8

1 reference

11 February 2018

issue

11

1 reference

11 February 2018

page(s)

1270-1275

1 reference

11 February 2018

https://scigraph.springernature.com/pub.10.1038/nm783

exact match

0 references

cites work

Alzheimer's disease: genes, proteins, and therapy

1 reference

7 January 2021

Potential treatment opportunities for Alzheimer's disease through inhibition of secretases and Abeta immunization

1 reference

7 January 2021

Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo

1 reference

7 January 2021

A learning deficit related to age and beta-amyloid plaques in a mouse model of Alzheimer's disease

1 reference

7 January 2021

Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity

1 reference

7 January 2021

Formation of neurofibrillary tangles in P301l tau transgenic mice induced by Abeta 42 fibrils

1 reference

7 January 2021

Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse

1 reference

7 January 2021

Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease

1 reference

7 January 2021

Immunization with a nontoxic/nonfibrillar amyloid-beta homologous peptide reduces Alzheimer's disease-associated pathology in transgenic mice

1 reference

7 January 2021

A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease

1 reference

7 January 2021

A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease

1 reference

7 January 2021

Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease

1 reference

7 January 2021

Brain to plasma amyloid-beta efflux: a measure of brain amyloid burden in a mouse model of Alzheimer's disease.

1 reference

7 January 2021

Disaggregation of Alzheimer beta-amyloid by site-directed mAb.

1 reference

7 January 2021

Imaging of amyloid-beta deposits in brains of living mice permits direct observation of clearance of plaques with immunotherapy.

1 reference

7 January 2021

Call for Elan to publish Alzheimer's trial details.

1 reference

7 January 2021

Correlative Memory Deficits, Abeta Elevation, and Amyloid Plaques in Transgenic Mice

1 reference

7 January 2021

Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1

1 reference

7 January 2021

Accelerated Alzheimer-type phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes

1 reference

7 January 2021

Prominent cerebral amyloid angiopathy in transgenic mice overexpressing the london mutant of human APP in neurons.

1 reference

7 January 2021

Neuronal overexpression of mutant amyloid precursor protein results in prominent deposition of cerebrovascular amyloid

1 reference

7 January 2021

1 reference

7 January 2021

T- and B-cell responses to myelin oligodendrocyte glycoprotein in experimental autoimmune encephalomyelitis and multiple sclerosis

1 reference

7 January 2021

Amyloid beta peptide as a vaccine for Alzheimer's disease involves receptor-mediated transport at the blood-brain barrier.

1 reference

7 January 2021

Autoantibodies to amyloid-beta and Alzheimer's disease.

1 reference

7 January 2021

Immune hyporesponsiveness to amyloid beta-peptide in amyloid precursor protein transgenic mice: implications for the pathogenesis and treatment of Alzheimer's disease

1 reference

7 January 2021

Nerve inflammation halts trial for Alzheimer's drug.

1 reference

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

7 January 2021

1 reference

7 January 2021

Identifiers

DOI

10.1038/NM783

1 reference

11 February 2018

Dimensions Publication ID

1022800056

0 references

1 reference

11 February 2018